Another limitation of our study in this context was not assessing pro-inflammatory cytokine-producing T cell subtypes and thus the inflammation status of our PD patients and suppression capacity of CD49d+ Tregs could not be duly investigated. This evidence concerns the gene ITGA4 and Parkinson disease.